Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
The (pro)renin receptor: an emerging player in tumorigenesis
FY 2020-21
Summary
According to the Canadian Cancer Society, 1 out of 4 Canadians is expected to die from cancer. Studying emerging players in cancer allows us to identify novel therapeutic targets. This research slowly, but surely, paves the way to a cancer-less world. The (pro)renin receptor (PRR) is an emerging player in tumorigenesis, or tumor formation, as it engages cell signaling pathways central to cancer biology. However, how PRR contributes to tumorigenesis remains elusive. The Wnt/β-catenin pathway is highly activated in cancer. PRR is essential in Wnt/β-catenin signaling because it is needed for assembling the vacuolar H+-adenosine triphosphatase (V-ATPase) complex. The V-ATPase complex is required for Wnt ligand binding to the Wnt receptor complex and for the cellular internalization of the Wnt receptor complex, which are key processes in Wnt/β-catenin signaling. The PRR can be processed into two fragments: soluble PRR (sPRR) and the M8.9 fragment. When measured clinically, levels of sPRR were elevated in cancer patients of several cancer types. The M8.9 fragment is the predominant PRR structure associated with the V-ATPase complex. This data suggests a pertinent role of PRR processing in tumorigenesis, possibly through Wnt/β-catenin signaling. To test this hypothesis, our lab generated a mouse model with aberrant PRR processing, as suggested by reduced plasma sPRR levels, through introducing mutations in the PRR gene processing sites. Mating these mice with a cancer mouse model will allow assessing whether aberrant PRR processing decreases cancer susceptibility in living organisms. Using cellular models derived from these mice, experiments will be performed to elucidate the effect of aberrant PRR processing on V-ATPase function, Wnt/β-catenin signaling, and tumorigenesis.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
449462
Name
Abuloghod Lama
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The (pro)renin receptor: an emerging player in tumorigenesis
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Atp6ap2; Prorenin Receptor; Tumorigenesis; V-Atpase Complex; Wnt/ß-Catenin
Abstract
According to the Canadian Cancer Society, 1 out of 4 Canadians is expected to die from cancer. Studying emerging players in cancer allows us to identify novel therapeutic targets. This research slowly, but surely, paves the way to a cancer-less world. The (pro)renin receptor (PRR) is an emerging player in tumorigenesis, or tumor formation, as it engages cell signaling pathways central to cancer biology. However, how PRR contributes to tumorigenesis remains elusive. The Wnt/β-catenin pathway is highly activated in cancer. PRR is essential in Wnt/β-catenin signaling because it is needed for assembling the vacuolar H+-adenosine triphosphatase (V-ATPase) complex. The V-ATPase complex is required for Wnt ligand binding to the Wnt receptor complex and for the cellular internalization of the Wnt receptor complex, which are key processes in Wnt/β-catenin signaling. The PRR can be processed into two fragments: soluble PRR (sPRR) and the M8.9 fragment. When measured clinically, levels of sPRR were elevated in cancer patients of several cancer types. The M8.9 fragment is the predominant PRR structure associated with the V-ATPase complex. This data suggests a pertinent role of PRR processing in tumorigenesis, possibly through Wnt/β-catenin signaling. To test this hypothesis, our lab generated a mouse model with aberrant PRR processing, as suggested by reduced plasma sPRR levels, through introducing mutations in the PRR gene processing sites. Mating these mice with a cancer mouse model will allow assessing whether aberrant PRR processing decreases cancer susceptibility in living organisms. Using cellular models derived from these mice, experiments will be performed to elucidate the effect of aberrant PRR processing on V-ATPase function, Wnt/β-catenin signaling, and tumorigenesis.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Abuloghod, Lama
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~